Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF ONCOLOGY
Volume 43, Issue 3, Pages 895-902
Publisher
Spandidos Publications
Online
2013-06-27
DOI
10.3892/ijo.2013.1995
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- (2012) Peter M Rothwell et al. LANCET
- Phospho-Sulindac (OXT-328) Inhibits the Growth of Human Lung Cancer Xenografts in Mice: Enhanced Efficacy and Mitochondria Targeting by its Formulation in Solid Lipid Nanoparticles
- (2012) Rongrong Zhu et al. PHARMACEUTICAL RESEARCH
- Phosphosulindac (OXT-328) Selectively Targets Breast Cancer Stem Cells In Vitro and in Human Breast Cancer Xenografts
- (2012) Caihua Zhu et al. STEM CELLS
- Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer
- (2011) H. Yin et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- The metabolism and pharmacokinetics of phospho-sulindac (OXT-328) and the effect of difluoromethylornithine
- (2011) G Xie et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
- (2011) Gerardo G. Mackenzie et al. Cancer Prevention Research
- Chemotherapeutic Properties of Phospho-Nonsteroidal Anti-Inflammatory Drugs, a New Class of Anticancer Compounds
- (2011) L. Huang et al. CANCER RESEARCH
- Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy
- (2011) Jen-Yi Lee et al. PLoS One
- Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells
- (2010) Yan Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin potentiates the pro-apoptotic effects of sulindac sulfone in colorectal cancer
- (2010) Nis Giladi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Chemopreventive effect of dietary curcumin on inflammation-induced colorectal carcinogenesis in mice
- (2010) Isabel Villegas et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Lung tumor promotion by curcumin
- (2009) Stephanie T. Dance-Barnes et al. CARCINOGENESIS
- Aspirin, salicylates, and cancer
- (2009) Peter C Elwood et al. LANCET
- Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
- (2009) B. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Coadministration of Paclitaxel and Curcumin in Nanoemulsion Formulations To Overcome Multidrug Resistance in Tumor Cells
- (2009) Srinivas Ganta et al. MOLECULAR PHARMACEUTICS
- Curcumin Inhibits the Activity of ABCG2/BCRP1, a Multidrug Resistance-Linked ABC Drug Transporter in Mice
- (2008) Suneet Shukla et al. PHARMACEUTICAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started